Specifically around use in secondary care:
Isn't it widely believed that eGFR isn't a valid estimate of GFR when renal function is rapidly changing? I don't think that plasma creatinine stops being a valid estimate of plasma creatinine in that situation.
For laboratories that report eGFR in secondary care for the specific function of improving drug dosing please could they say which formula they use. Isn't it better for this purpose to use one that includes the patient's mass?
Jonathan
On 18 Mar 2011, at 16:45, EDMUND LAMB wrote:
>
> Those concerned about reporting eGFR in inpatients because of rapidly changing cardiovascular or renal function, presumably don't report creatinine in such patients either?
>
> Edmund
>
>
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|